Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Sales | 4,430,000 | 4,446,000 | 4,441,000 | 4,151,000 | 4,064,000 |
| Cost of Goods | 1,206,000 | 1,152,000 | 1,179,000 | 1,110,000 | 1,097,000 |
| Gross Profit | 3,224,000 | 3,294,000 | 3,262,000 | 3,041,000 | 2,967,000 |
| Operating Expenses | 2,060,000 | 2,002,000 | 2,185,000 | 1,845,000 | 1,935,000 |
| Operating Income | 1,164,000 | 1,292,000 | 1,077,000 | 1,196,000 | 1,032,000 |
| Other Income | 0 | 0 | 44,000 | 0 | 0 |
| Pre-tax Income | 1,164,000 | 1,292,000 | 1,121,000 | 1,196,000 | 1,032,000 |
| Income Tax | 329,000 | 365,000 | 319,000 | 341,000 | 294,000 |
| Net Income Continuous | 835,000 | 927,000 | 802,000 | 855,000 | 738,000 |
| Net Income | $835,000 | $927,000 | $802,000 | $855,000 | $738,000 |
| EPS Basic Total Ops | 0.42 | 0.47 | 0.41 | 0.43 | 0.37 |
| EPS Basic Continuous Ops | 0.42 | 0.47 | 0.40 | 0.43 | 0.37 |
| EPS Diluted Total Ops | 0.41 | 0.46 | 0.39 | 0.43 | 0.37 |
| EPS Diluted Continuous Ops | 0.41 | 0.46 | 0.39 | 0.43 | 0.37 |
| EBITDA(a) | $1,310,000 | $1,447,000 | $1,259,000 | $1,336,000 | $1,167,000 |